Obesity

Adults who reported high levels of perceived stress, particularly throughout early childhood, adolescence and early adulthood, were much more likely to develop cardiometabolic risk factors than those with low perceived stress, data show.

An increase in symptoms of depression was linked to a small increase in weight among adults with overweight or obesity, according to a recent study in PLOS One.

Adults with type 2 diabetes who use GLP-1 receptor agonists do not have an increased short-term risk for pancreatic cancer, according to findings published in JAMA Network Open.

Preliminary results from an ongoing FDA investigation found no evidence that weight-loss drugs cause suicidal ideations and aspirations, although the agency said it cannot rule out a risk entirely.

Patients with CAD who enrolled in cardiac rehab saw a 42.7% reduction in all-cause hospital readmission or death vs. those who did not attend sessions, a much larger effect size than seen in previous cardiac rehab studies, data show.

Exposure to plastics containing endocrine-disrupting chemicals added an estimated $249 billion to health care costs in the U.S. in 2018, according to study data.

Adults receiving semaglutide as a type 2 diabetes or obesity medication have a lower risk for suicidal ideation than those who are using a drug that is not a GLP-1 receptor agonist, according to findings published in Nature Medicine.

In the landscape of health care, the year 2023 witnessed remarkable strides in the field of obesity medicine.

Children with obesity demonstrate a greater likelihood of shock, ICU admission and worse laboratory scores in multisystem inflammatory syndrome, but not Kawasaki disease, according to data published in JAMA Network Open.

Low levels of the cytokines interleukin-4 and interleukin-17 were associated with an increased risk for coronary artery disease, data show.